Search results for abx831549

Gremubamab, Abbexa, abx831549

Gremubamab is a monoclonal antibody biosimilar expressed in CHO cells, targeting Bradyrhizobium sp. PcrV, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Gremubamab is under investigation in clinical trial NCT02255760 (Phase 1 Randomized Double-blind Placebo Controlled Study to Evaluate Safety and PK of MEDI3902 in Healthy Adults).